Kimberly-Clark (NYSE:KMB – Get Free Report) had its target price decreased by analysts at Barclays from $144.00 to $132.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target points to a potential upside of 3.51% from the stock’s current price.
KMB has been the subject of a number of other reports. UBS Group cut their price objective on Kimberly-Clark from $151.00 to $132.00 and set a “neutral” rating for the company in a report on Thursday. Piper Sandler reduced their price target on shares of Kimberly-Clark from $175.00 to $161.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada restated an “outperform” rating and issued a $165.00 price objective on shares of Kimberly-Clark in a report on Wednesday, October 23rd. TD Cowen lowered shares of Kimberly-Clark from a “buy” rating to a “hold” rating and set a $145.00 target price on the stock. in a report on Wednesday, January 8th. Finally, Wells Fargo & Company cut their price target on shares of Kimberly-Clark from $140.00 to $130.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 7th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Kimberly-Clark has an average rating of “Hold” and a consensus price target of $143.71.
Kimberly-Clark Price Performance
Kimberly-Clark (NYSE:KMB – Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.14. Kimberly-Clark had a net margin of 12.97% and a return on equity of 198.59%. The firm had revenue of $4.95 billion for the quarter, compared to analyst estimates of $5.06 billion. During the same quarter in the prior year, the firm earned $1.74 EPS. The business’s revenue for the quarter was down 3.5% compared to the same quarter last year. As a group, analysts predict that Kimberly-Clark will post 7.31 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, VP Andrew Drexler sold 3,000 shares of the company’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $139.01, for a total value of $417,030.00. Following the sale, the vice president now directly owns 5,053 shares of the company’s stock, valued at $702,417.53. This represents a 37.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.62% of the stock is currently owned by company insiders.
Institutional Trading of Kimberly-Clark
A number of hedge funds have recently modified their holdings of the business. Edgestream Partners L.P. purchased a new stake in Kimberly-Clark in the second quarter worth about $731,000. XTX Topco Ltd boosted its position in shares of Kimberly-Clark by 305.0% in the 2nd quarter. XTX Topco Ltd now owns 11,822 shares of the company’s stock worth $1,634,000 after purchasing an additional 8,903 shares in the last quarter. Brighton Jones LLC grew its stake in shares of Kimberly-Clark by 16.4% in the 2nd quarter. Brighton Jones LLC now owns 6,515 shares of the company’s stock worth $900,000 after buying an additional 917 shares during the last quarter. Ieq Capital LLC increased its position in Kimberly-Clark by 23.6% during the 2nd quarter. Ieq Capital LLC now owns 19,212 shares of the company’s stock valued at $2,655,000 after buying an additional 3,669 shares in the last quarter. Finally, Trust Investment Advisors purchased a new position in Kimberly-Clark during the second quarter valued at $209,000. Institutional investors own 76.29% of the company’s stock.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Further Reading
- Five stocks we like better than Kimberly-Clark
- Investing In Automotive Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How to invest in marijuana stocks in 7 steps
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.